These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9659874)

  • 21. Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.
    Mundo E; Bellodi L; Smeraldi E
    Biol Psychiatry; 1995 Oct; 38(8):525-31. PubMed ID: 8562664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine and clomipramine in obsessive-compulsive disorder.
    Lipsedge MS; Prothero W
    Am J Psychiatry; 1987 Jul; 144(7):965-6. PubMed ID: 3605413
    [No Abstract]   [Full Text] [Related]  

  • 23. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience in the treatment of obsessional states (2).
    Rack PH
    J Int Med Res; 1977; 5 Suppl 5():81-90. PubMed ID: 598609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous clomipramine and obsessive-compulsive disorder.
    Thakur AK; Remillard AJ; Meldrum LH; Gorecki DK
    Can J Psychiatry; 1991 Sep; 36(7):521-4. PubMed ID: 1933762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
    Zink M; Knopf U; Kuwilsky A
    Aust N Z J Psychiatry; 2007 Mar; 41(3):293-4. PubMed ID: 17464712
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.
    Yamauchi K; Ohta K; Taniguchi T; Ohmori T
    Gen Hosp Psychiatry; 2004; 26(3):242-3. PubMed ID: 15121355
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of clomipramine in treatment of obsessive-compulsive symptomatology.
    Stroebel CF; Szarek BL; Glueck BC
    J Clin Psychopharmacol; 1984 Apr; 4(2):98-100. PubMed ID: 6707247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amantadine augmentation for refractory obsessive-compulsive disorder: a case report.
    Pasquini M; Berardelli I; Biondi M
    J Clin Psychopharmacol; 2010 Feb; 30(1):85-6. PubMed ID: 20075660
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
    Leonard HL; Swedo SE; Lenane MC; Rettew DC; Cheslow DL; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1991 Oct; 48(10):922-7. PubMed ID: 1929762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
    Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT; Hill JL; Murphy DL
    Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine treatment of delusional disorder, somatic type.
    Wada T; Kawakatsu S; Nadaoka T; Okuyama N; Otani K
    Int Clin Psychopharmacol; 1999 May; 14(3):181-3. PubMed ID: 10435772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of compulsive sexual behaviour with clomipramine and valproic acid.
    Gulsun M; Gulcat Z; Aydin H
    Clin Drug Investig; 2007; 27(3):219-23. PubMed ID: 17305416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.
    Judd FK; Chua P; Lynch C; Norman T
    Aust N Z J Psychiatry; 1991 Sep; 25(3):412-4. PubMed ID: 1958165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.